Patents by Inventor Behrend F. Lundt

Behrend F. Lundt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-substituted azaheterocyclic carboxylic acids and esters thereof
    Patent number: 5635518
    Abstract: The present invention relates to therapeutically active azaheterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a central nervous system ailment related to the GABA uptake.
    Type: Grant
    Filed: June 22, 1994
    Date of Patent: June 3, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Hans Petersen, Knud E. Andersen, Per O. S.o slashed.rensen, Jesper Lau, Behrend F. Lundt
  • 1-substituted, 3-carboxylic acid piperidine derivatives
    Patent number: 5608069
    Abstract: The present invention relates to therapeutically active azaheterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a central nervous system ailment related to the GABA uptake.
    Type: Grant
    Filed: June 22, 1994
    Date of Patent: March 4, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Hans Petersen, Knud E. Andersen, Per O. S.o slashed.rensen, Jesper Lau, Henning B. Petersen, Behrend F. Lundt
  • Heterocyclic chemistry
    Patent number: 5604242
    Abstract: The present invention relates to therapeutically active azaheterocyclic compounds, a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a central nervous system ailment related to the GABA uptake.
    Type: Grant
    Filed: June 22, 1994
    Date of Patent: February 18, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Hans Petersen, Knud E. Andersen, Per O. S.o slashed.rensen, Jesper Lau, Behrend F. Lundt
  • N-substituted azaheterocyclic carboxylic acids
    Patent number: 5348965
    Abstract: The invention relates to therapeutically active azaheterocyclic compounds and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in treating a central nervous system ailment related to the GABA uptake.
    Type: Grant
    Filed: May 14, 1992
    Date of Patent: September 20, 1994
    Assignee: Novo Nordisk A/S
    Inventors: Knud E. Andersen, Lars J. S. Knutsen, Per O. Sorensen, Behrend F. Lundt, Jesper Lau, Hans Petersen
  • Use of peptides as medicaments and certain novel peptides
    Patent number: 4598065
    Abstract: Certain peptides containing the glucagon.sub.1-21 peptide chain His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Al a-Gln-Asp, usable as a medicament or a diagnostic; the peptide exerts a spasmolytic effect and an inhibitory effect on gastric acid secretion similar to glucagon with not more than a negligible metabolic effect. Some of the glucagon fragments are novel compounds.
    Type: Grant
    Filed: June 30, 1981
    Date of Patent: July 1, 1986
    Assignee: Novo Industri A/S
    Inventors: Behrend F. Lundt, Karin D. Jorgensen, Nils L. Johansen, Frederik C. Gronvald, Erik K. Frandsen, Alister J. Moody, Jan Markussen